Given Novartis is going to ramp up their products in the next few weeks, I agree Telix should start and update investors on how they are responding to this development. Telix can't keep pushing the timeline out (they must have done it multiple times by now).
While Telix can't predict the Novartis schedule, I'm sure they still knew the risk of what would happen after a large company receives FDA approval.
Until we get an update, I think the share price will just stay where it is.
Also wasn't a good look that the CEO sold out as part of the capital raising. I wish I hadn't ignored this.
Given Novartis is going to ramp up their products in the next...
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.48 |
Change
0.030(0.15%) |
Mkt cap ! $6.854B | |||
| Open | High | Low | Value | Volume |
| $20.35 | $20.83 | $20.30 | $10.68M | 520.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1586 | $20.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.58 | 898 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |